Drug Shortage Report for LUSTRA-AF
Report ID | 2113 |
Drug Identification Number | 02242934 |
Brand name | LUSTRA-AF |
Common or Proper name | Lustra-AF |
Company Name | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OCTINOXATE HYDROQUINONE AVOBENZONE |
Strength(s) | 7.5% 4% 3% |
Dosage form(s) | CREAM |
Route of administration | TOPICAL |
Packaging size | 28.4 g |
ATC code | D11AX |
ATC description | OTHER DERMATOLOGICAL PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2015-01-01 |
Actual start date | 2015-01-01 |
Estimated end date | Unknown |
Actual end date | 2015-06-30 |
Shortage status | Resolved |
Updated date | 2019-08-19 |
Company comments | Discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2019-08-19 | French | Compare |
v3 | 2019-08-19 | English | Compare |
v2 | 2017-03-14 | French | Compare |
v1 | 2017-03-14 | English | Compare |
Showing 1 to 4 of 4